US to exempt UK pharmaceuticals and ingredients under trade deal

Core Viewpoint - The U.S. government will exempt U.K.-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from current and future tariffs as part of a negotiated agreement in principle [1] Group 1: Tariff Exemption - U.K.-origin pharmaceuticals will be exempt from tariffs imposed under two U.S. laws [1] - Pharmaceutical ingredients from the U.K. will also be exempt from these tariffs [1] - Medical technology from the U.K. will benefit from the tariff exemption as well [1]